Akorn Recalls COSOPT Ophthalmic Solution Due to Stability Failures
Akorn Inc. is recalling 30,794 bottles of COSOPT Ophthalmic Solution because the product failed stability specifications for opalescence.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences, fitting the 'Low' severity criteria for documentation or minor specification issues.
Plain-English summary
Akorn Inc. is recalling 30,794 bottles of COSOPT Ophthalmic Solution, USP (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle. The recall involves lots 426007 and 426008 with an expiration date of 4/2020. The product is distributed nationwide in the United States and Puerto Rico.
The recall was initiated because the product failed stability specifications, specifically showing out-of-specification results for opalescence during a 7-month stability study. The U.S. Food and Drug Administration has classified this as a Class III recall.
Consumers should stop using the affected product and contact their healthcare provider or pharmacist for guidance on replacement or disposal. The recalled product is identified by NDC 17478-605-10.
The recalled product
- Product
- COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle, Sterile, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL, NDC: 17478-605-10
- Manufacturer
- Akorn Inc
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 30,794
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 426007 and 426008
- exp 4/2020
Distribution
Related recalls
Same manufacturer · Akorn Inc
See all →- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · stability failure
See all →- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
Similar recalls
- HighTimolol Maleate Ophthalmic Solution Recalled for Manufacturing and Stability Testing Defects
FDA (Drugs) · 2023-06-07
- ModerateAkorn Atropine Sulfate Eye Solution Recalled for Failed Stability Testing
FDA (Drugs) · 2023-02-15
- LowAkorn Recalls Atropine Sulfate Ophthalmic Solution Due to Viscosity Failure
FDA (Drugs) · 2018-03-14
- ModerateCardinal Health Recalls COSOPT Eye Drops Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateTimolol Maleate eye drops recalled for unknown impurity in stability testing
FDA (Drugs) · 2022-09-07
- HighEye-drop drug recall: Timolol solution due to manufacturing deviations
FDA (Drugs) · 2023-01-25